Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-111503
Filing Date
2025-11-13
Accepted
2025-11-13 17:29:51
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-3 tm2530769-1_s3.htm S-3 397109
2 EXHIBIT 4.3 tm2530769d2_ex4-3.htm EX-4.3 354084
3 EXHIBIT 5.1 tm2530769d2_ex5-1.htm EX-5.1 27177
4 EXHIBIT 23.2 tm2530769d2_ex23-2.htm EX-23.2 2551
5 EX-FILING FEES tm2530769d1_ex-filingfees.htm   iXBRL EX-FILING FEES 50736
6 GRAPHIC lg_coherusoncology-4c.jpg GRAPHIC 22029
7 GRAPHIC tm2530769d2_ex5-1img001.jpg GRAPHIC 8669
8 GRAPHIC tm2530769d2_ex5-1img002.jpg GRAPHIC 5946
  Complete submission text file 0001104659-25-111503.txt   1056708

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2530769d1_ex-filingfees_htm.xml XML 17070
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-291520 | Film No.: 251479928
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)